论文部分内容阅读
恩丹西酮（Ｏｎｄａｎｓｅｔｏｎ）治疗抗癌药物引起的恶心、呕吐反应７２例，分三组观察。第１组为非顺氯铵铂（ＤＤＰ），含ＡＤＭ、ＣＴＸ组。于化疗前给恩丹西酮，静注，８ｍｇ，次日口服恩丹西酮４ｍｇ，每日２次，共用１天。其疗效第１天１００％；第２～３天为８１．８％，９６．９％；第４～５天为１００％。第２组为含ＤＤＰ组，输ＤＤＰ之日静注恩丹西酮８ｍｇ，次日口服本药４ｍｇ，１日２次，连服２天，其疗效第１～３天分别为７５．７％，８１．８％，９６．９％，第４～５天为１００％。第３组亦为含有ＤＤＰ加氟美松１０ｍｇ，用法同第２组，其止吐疗效第１～３天为９０．９％，第４～５天为１００％。结果，恩丹西酮加氟美松的效果９０．９％，比单用恩丹西酮组的疗效７５．５％～９６．９％优越。
Ondanseton treatment of anticancer drugs caused by nausea and vomiting in 72 cases, divided into three groups observed. The first group is non-cisplatin platinum (DDP), containing ADM, CTX group. Ondansetron before chemotherapy, intravenous injection, 8mg, oral administration of ondansetron 4mg the next day, 2 times a day for 1 day. The efficacy of the first day 100%; the first two days to 81.8%, 96.9%; the first four days to 100%. The second group was DDP group, DDP on the intravenous infusion of ondansetron 8mg, the next day oral administration of the drug 4mg, 1 day 2 times, and even served 2 days, the efficacy of 1 to 3 days were 75.7% , 81.8%, 96.9%, 100% on the 4th to 5th days. The third group also contains DDP plus dexamethasone 10mg, the same usage as Group 2, the antiemetic efficacy of 1 to 3 days 90.9%, 4 to 5 days to 100%. The results, ondansetron and dexamethasone 90.9%, than ondansetron alone group efficacy of 75.5% to 96.9% superior.